Pingkun Zhou
Molecular Biology · 2020–2021
A researcher in the Science corpus: 2 papers; trusts 5 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 65 citations into it
- Cancer Research — 17 citations into it
- Cell Biology — 7 citations into it
Whom Pingkun Zhou trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Jan H. J. Hoeijmakers (in Molecular Biology)
- Stephen P. Jackson (in Molecular Biology)
- Stephen J. Elledge (in Molecular Biology)
- Andrew N. Blackford (in Molecular Biology)
- Tomas Lindahl (in Molecular Biology)
Papers from Pingkun Zhou's perspective
Ordered by how strongly the researchers Pingkun Zhou trusts endorse each paper. Same corpus, a different order for every researcher.
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase (Nature)
- 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks (Cell)
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis (Nature)
- DNA repair pathways as targets for cancer therapy (Nature Reviews. Cancer)
- Genomic instability — an evolving hallmark of cancer (Nature reviews. Molecular cell biology)
- Repair of endogenous DNA damage. (Cold Spring Harbor Symposia on Quantitative Biology)
- The DNA damage response and cancer therapy (Nature)
- Genome maintenance mechanisms for preventing cancer (Nature)
- The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor (Nature)
- Landscape of somatic mutations in 560 breast cancer whole genome sequences (Nature)